Zevia Pbc

Market Movers (8-K)

NYSE
Zevia PBC announced the results of its 2026 Annual Meeting of Stockholders, including the election of two Class II directors and the ratification of its independent auditor.
NYSE
Zevia PBC announced the appointment of Alexandre Ruberti as its new CEO, succeeding Amy Taylor, and revised its second quarter 2026 outlook to the high end of guidance for net sales and at or above prior expectations for Adjusted EBITDA.
NYSE
Zevia PBC's subsidiary, Zevia LLC, has amended its Loan and Security Agreement, extending the maturity date to February 22, 2030, and adjusting credit spread and financial covenants.
NYSE
Zevia PBC announced first quarter 2026 results, with net sales increasing 21.2% year-over-year to $46.1 million, exceeding expectations and achieving positive Adjusted EBITDA.
Better than expected
NYSE
Zevia reports improved financial performance for Q4 and full year 2025, with net loss and Adjusted EBITDA showing significant improvements, alongside a new Board Chair appointment.
Better than expected
NYSE
Zevia PBC announced the appointment of Suzanne Ginestro, CMO of Califia Farms, as an independent director to its Board, effective January 7, 2026, while Justin Shaw will step down on February 24, 2026.

Quarterly Earnings (10-Q)

NYSE
Zevia PBC reported a 21.2% increase in net sales for Q1 2026, driven by higher volumes and expanded distribution, though net loss widened slightly.
Capital raise
NYSE
Zevia PBC announced its third-quarter and nine-month results for 2025, showing increased net sales and significant improvement in nine-month profitability, despite a slight dip in Q3 net loss and gross margin.
Capital raise
Better than expected
NYSE
Zevia PBC reported a significant reduction in net loss and a substantial increase in gross profit and sales for the second quarter of 2025, driven by its Productivity Initiative and expanded distribution.
Better than expected
NYSE
Zevia PBC's Q1 2025 results show a slight decrease in net sales, but improved gross profit margin due to ongoing productivity initiatives.
NYSE
Zevia PBC's Q3 2024 results show a decrease in net sales and a focus on cost-cutting measures amid distribution changes and a competitive market.
Worse than expected
NYSE
Zevia PBC's second quarter results show a decrease in net sales and a strategic restructuring initiative aimed at improving efficiency and brand investment.
Worse than expected
Delay expected

Annual Reports (10-K)

NYSE
Zevia PBC reported a significant reduction in net loss for 2025, driven by increased net sales and benefits from its multi-year Productivity Initiative, despite ongoing macroeconomic challenges and tariff impacts.
Capital raise
Better than expected
NYSE
Zevia PBC's 2024 results show a decrease in net sales but highlight a productivity initiative aimed at improving cost structure and brand investment.
Worse than expected
NYSE
Zevia PBC has granted stock options and restricted stock units to its senior executives and board members under its 2021 Equity Incentive Plan.

Insider Trading (Form 4)

NYSE
Zevia PBC CEO Alexandre Ruberti was granted 1,013,133 restricted stock units as part of his appointment effective June 15, 2026.
NYSE
Director Suzanne Ginestro was granted 72,464 restricted stock units as part of the Zevia PBC 2021 Equity Incentive Plan.
NYSE
Director Padraic L. Spence was granted 72,464 restricted stock units in Zevia PBC as part of the company's 2021 Equity Incentive Plan.
NYSE
Director Julie Garcia Ruehl was granted 72,464 restricted stock units in Zevia PBC, vesting in June 2027.
NYSE
Zevia PBC Director David J. Lee was granted 72,464 restricted stock units as part of the company's 2021 Equity Incentive Plan.
NYSE
Director Andrew Ruben was granted 72,464 restricted stock units in Zevia PBC, vesting in June 2027.

Proxy Statements (Def-14A)

NYSE
Zevia PBC has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and auditor ratification.
NYSE
Zevia PBC announces its 2025 Annual Meeting to be held on June 12, 2025, providing details on how stockholders can vote and access proxy materials.
NYSE
Zevia PBC announces its 2025 Annual Meeting of Stockholders to be held virtually on June 12, 2025, with proposals including the election of three Class I directors and ratification of Deloitte & Touche LLP as the independent auditor.
Worse than expected
NYSE
Zevia PBC informs stockholders of a change in the name of the venue for the 2024 Annual Meeting, now to be held at Sandbourne Santa Monica, Autograph Collection (formerly named Le Merigot Santa Monica).
NYSE
Zevia PBC announces its 2023 Annual Meeting of Stockholders to be held on June 11, 2024, outlining key voting items including the election of directors and ratification of the company's accounting firm.
NYSE
Zevia PBC's 2024 Annual Meeting of Stockholders will address the election of two Class III directors and the ratification of Deloitte & Touche LLP as the independent accounting firm.
Worse than expected

Schedule 13D - Activist Investments

NYSE
Caisse de dépôt et placement du Québec (CDPQ) filed an amendment to its Schedule 13D confirming its continued beneficial ownership of 15.9% of Zevia PBC's Class A common stock.
NYSE
CDP Investissements Inc. and Caisse de depot et placement du Quebec filed an amendment to their Schedule 13D, reaffirming a 20.1% beneficial ownership in Zevia PBC.
NYSE
Caisse de depot et placement du Quebec and its subsidiary CDP Investissements Inc. reaffirmed their beneficial ownership of 25.3% of Zevia PBC's Class A Common Stock.
NYSE
CDP Investissements Inc. and Caisse de depot et placement du Quebec have filed an amended Schedule 13D, confirming their beneficial ownership of 20,022,092 shares, representing 30.3% of Zevia PBC's Class A Common Stock.

Schedule 13G - Passive Investments

NYSE
Tallwoods Investments, LLC and Gabriel S. Plotkin have filed an amended Schedule 13G, reporting a 1.0% beneficial ownership stake in Zevia PBC's Class A Common Stock.
NYSE
Divisadero Street Capital Management, LP and related entities disclose a 4.8% beneficial ownership stake in Zevia PBC's Class A Common Stock.
NYSE
Topline Capital Management, LLC and its affiliates have reported a significant passive ownership stake of 8.8% in Zevia PBC's Class A Common Stock.
NYSE
Divisadero Street Capital Management and affiliated entities reported a 9.1% beneficial ownership stake in Zevia PBC's Class A Common Stock.
NYSE
Divisadero Street Capital Management and affiliated entities reported a 9.1% beneficial ownership stake in Zevia PBC's Class A Common Stock.
NYSE
Divisadero Street Capital Management, along with related entities and William Zolezzi, filed a Schedule 13G indicating beneficial ownership of 5.4% of Zevia PBC's Class A Common Stock as of July 7, 2025.